NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 147221-93-0
Drug Levels and Effects
Summary of Use during Lactation
No published information is available on the use of delavirdine during breastfeeding. Delavirdine is not a recommended agent during breastfeeding.[1,2]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- AIDSinfo. Panel on treatment of pregnant women with HIV infection and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in transmission in the United States, 2018: Counseling and management of women living with HIV who breastfeed. https://aidsinfo
.nih .gov/guidelines/html /3/perinatal/513/counseling-and-management-of-women-living-with-hiv-who-breastfeed. - 2.
- World Health Organization. HIV and infant feeding: Update. 2007. http://whqlibdoc
.who .int/publications/2007 /9789241595964_eng.pdf.
Substance Identification
Substance Name
Delavirdine
CAS Registry Number
147221-93-0
Drug Class
Breast Feeding
Anti-Infective Agents
Anti-HIV Agents
Antiviral Agents
Anti-Retroviral Agents
Reverse Transcriptase Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidate.[J Med Chem. 1993]Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidate.Romero DL, Morge RA, Genin MJ, Biles C, Busso M, Resnick L, Althaus IW, Reusser F, Thomas RC, Tarpley WG. J Med Chem. 1993 May 14; 36(10):1505-8.
- Review Pindolol[Drugs and Lactation Database (...]Review Pindolol. Drugs and Lactation Database (LactMed). 2006
- Solid phases of delavirdine mesylate.[J Pharm Sci. 1996]Solid phases of delavirdine mesylate.Bergren MS, Chao RS, Meulman PA, Sarver RW, Lyster MA, Havens JL, Hawley M. J Pharm Sci. 1996 Aug; 85(8):834-41.
- Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.[Drug Metab Dispos. 1997]Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Hauer MJ, Zhang W, Branstetter DG. Drug Metab Dispos. 1997 Jul; 25(7):828-39.
- Review Olmesartan[Drugs and Lactation Database (...]Review Olmesartan. Drugs and Lactation Database (LactMed). 2006